A Coag Conversation: 100 Years of VWD and Upcoming Advances: Conversation 3

On August 11, 2026, we posted the third and concluding conversation of “100 Years of Von Willebrand Disease and Upcoming Advances” with Robert F. Sidonio, Jr., MD, MSc. Click here for #3: Advanced Assays and von Willebrand Disease Management.

Comments (0)

Bleeding Disorders

Aug 9 2026

george

ISTH Paris Summary

Thanks to Dr. Ali Sadeghi-Khomami, PBI Research Scientist, for this downloadable comprehensive summary of the ISTH meeting in Paris.

Events

Events and Conferences: Bleeding Disorders Conference August 13–15

Thanks to Elaine Benoit, PBI’s marketing guru, for recent updates to our Events and Conferences Calendar. This week is the NBDF’s Bleeding Disorders Conference in Orlando, FL, USA, August 13–15. It’s not too late to register. Our colleagues at George King Bio-Medical will exhibit at booth 100. If you don’t see your hemostasis-related event or […]

Events

ASH Coagulation Presentation Overview

The 67th ASH Annual Meeting is December 6–9 in Orlando, FL, USA. Here’s Dr. Wolfgang Miesback’s list of bleeding disorder presentations.

Bleeding Disorders

Gene Transfer Therapy Updates

Yesterday, 10-28-25, we reported BioMarin’s press release announcing divestiture of their hemophilia A gene transfer therapy, valoctocogene roxaparvovec (Roctavian®). Previously, on February 25, 2025, Pfizer announced their intention to discontinue hemophilia B gene transfer therapy, fidanacogene elaparvovec-dzkt (Becvez®). Press releases from both indicate underperformance in sales. The remaining hemophilia B therapy, etranacogene dezaparvovec-drlb (HEMGENIX®), CSL […]

Bleeding Disorders

BioMarin Plans to Divest Struggling Gene Therapy

Thanks to Dean Willett of Precision BioLogic Inc. for the heads-up on BioMarin’s 10-27-25 post announcing their divestment of the hemophilia A gene transfer therapy, Roctavian. See BioMarin’s 10-27 press release.

Bleeding Disorders

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Join me (Geo) and guest speaker Dr. Nicole Zantek, MD, PhD, Medical Director of the Special Coagulation Laboratory, Professor, Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, who discusses the pathophysiology of antiphospholipid antibodies, and alternative methods to monitor warfarin and DOAC anticoagulation in patients diagnosed with antiphospholipid syndrome. This is the […]

Comments (0)

Anticoagulant Therapy

Jun 28 2025

george

Differential Discussion: Hemophilia Part 2

On June 6, 2025, Malissa Norfolk and Dave Cabral posted George’s audio PowerPoint, “Have We Cured Hemophilia, Part 1?.” On June 25, Malissa and Dave posted “Have We Cured Hemophilia, Part 2?” Each video is 30″ long. Please feel free to watch and comment below.

Bleeding Disorders

Invent-VTE

In the ISTH annual meeting (June 21–25, 2025) I (Geo) met a representative of Invent-VTE, a non-profit dedicated to fostering international VTE research collaboration. Navigate to Hemostasis Agencies to see Invent-VTE‘s website and our complete list of hemostasis-related agencies.

Events

Webinar Summarizes ISLH Meeting 7–9 May, 2025

Click here to see our Precision BioLogic Inc. webinar summarizing our activities at the 7–9 May ISLH meeting in Halifax, NS, featuring PBI scientific staff Jon Geske, Ian Burns, Stephanie Henneberry, Mushfigur Rahman, and Tara Quinton. I (Geo) added a presentation describing the NASCOLA meeting. NASCOLA typically schedules its annual meeting to coincide with major […]

Comments (0)

Events

Events

A Coag Conversation: 100 Years of VWD and Upcoming Advances: Conversation 3

ISTH Paris Summary

Events and Conferences: Bleeding Disorders Conference August 13–15

ASH Coagulation Presentation Overview

Gene Transfer Therapy Updates

BioMarin Plans to Divest Struggling Gene Therapy

A Coag Conversation: Alternate Warfarin Monitoring When the Prothrombin Time is Unreliable – Part 1

Differential Discussion: Hemophilia Part 2

Invent-VTE

Webinar Summarizes ISLH Meeting 7–9 May, 2025

George Fritsma MS MLS

Cheat Sheets from George

Questions or Comments?

Quick Question